Ligand Pharmaceuticals Incorporated

NasdaqGM:LGND Stock Report

Mkt Cap: US$1.2b

Ligand Pharmaceuticals Financial Health

How is Ligand Pharmaceuticals's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: LGND's short term assets ($220.4M) exceed its short term liabilities ($135.2M).

Long Term Liabilities: LGND's short term assets ($220.4M) exceed its long term liabilities ($99.1M).


Debt to Equity History and Analysis

Debt Level: LGND has more cash than its total debt.

Reducing Debt: LGND's debt to equity ratio has reduced from 52.2% to 9.4% over the past 5 years.

Debt Coverage: LGND's debt is well covered by operating cash flow (146.2%).

Interest Coverage: LGND's interest payments on its debt are not well covered by EBIT (0.7x coverage).


Balance Sheet


Discover healthy companies